Varadarajulu, J., A. Schmitt, P. Falkai, M. Alsaif, C. W. Turck and D. Martins-de-Souza: Differential expression of HINT1 in schizophrenia brain tissue. In: European Archives of Psychiatry and Clinical Neuroscience 262, 2, 167-172 (2012).
Martins-de-Souza, D., W. F. Gattaz, A. Schmitt, G. Maccarrone, P. Falkai, S. Bahn, E. Dias-Neto and C. W. Turck: What does proteomics tell us about schizophrenia. In: Schizophrenia Bulletin 37, Suppl. 1, 116-117 (2011).
Wüstenberg, T., M. Begemann, C. Bartels, O. Gefeller, S. Stawicki, D. Hinze-Selch, A. Mohr, P. Falkai, J. B. Aldenhoff, M. Knauth, K.-A. Nave and H. Ehrenreich: Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. In: Molecular Psychiatry 16, 1, 26-36 (2011).
Martins-de-Souza, D., G. Maccarrone, T. Wobrock, I. Zerr, P. Gormanns, S. Reckow, P. Falkai, A. Schmitt and C. W. Turck: Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. In: Journal of Psychiatric Research 44, 16, 1176-1189 (2010).
Ribbe, K., H. Friedrichs, M. Begemann, S. Grube, S. Papiol, A. Kaestner, M. F. Gerchen, V. Ackermann, A. Tarami, A. Treitz, M. Floegel, L. Adler, J. B. Aldenhoff, M. Becker-Emner, T. Becker, A. Czernik, M. Dose, H. Folkerts, R. Freese, R. Guenther, S. Herpertz, D. Hesse, G. Kruse, H. Kunze, M. Franz, F. Loehrer, W. Maier, A. Mielke, R. Mueller-Isberner, C. Oestereich, F. G. Pajonk, T. Pollmaecher, U. Schneider, H. J. Schwarz, B. Kroener-Herwig, U. Havemann-Reinecke, J. Frahm, W. Stuehmer, P. Falkai, N. Brose, K. A. Nave and H. Ehrenreich: The cross-sectional GRAS sample: A comprehensive phenotypical data collection of schizophrenic patients.. In: BMC Psychiatry 10, Seq. No.: 91 (2010).
url: http://www.biomedcentral.com/content/pdf/1471-244X-10-91.pdf
doi: 10.1186/1471-244X-10-91
Martins-de-Souza, D., A. Schmitt, R. Roder, M. Lebar, T. Schneider-Axmann, P. Falkai and C. W. Turck: Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. In: Journal of Psychiatric Research 44, 14, 989-991 (2010).
Martins-De-Souza, D., T. Wobrock, I. Zerr, A. Schmitt, J. Gawinecka, T. Schneider-Axmann, P. Falkai and C. W. Turck: Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls. In: World Journal of Biological Psychiatry 11, 5, 719-728 (2010).
Martins-De-Souza, D., E. Dias-Neto, A. Schmitt, P. Falkai, P. Gormanns, G. Maccarrone, C. W. Turck and W. F. Gattaz: Proteome analysis of schizophrenia brain tissue. In: World Journal of Biological Psychiatry 11, 2, 110-120 (2010).
Martins-de-Souza, D., G. Maccarrone, S. Reckow, P. Falkai, A. Schmitt and C. W. Turck: Shotgun mass spectrometry analysis of the human thalamus proteome. In: Journal of Separation Science 32, 8 Sp. Iss. SI, 1231-1236 (2009).
Ehrenreich, H., D. Hinze-Selch, S. Stawicki, C. Aust, S. Knolle-Veentjer, S. Wilms, G. Heinz, S. Erdag, H. Jahn, D. Degner, M. Ritzen, A. Mohr, M. Wagner, U. Schneider, M. Bohn, M. Huber, A. Czernik, T. Pollmacher, W. Maier, A.-L. Sirén, J. Klosterkötter, P. Falkai, E. Rüther, J. B. Aldenhoff and H. Krampe: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. In: Molecular Psychiatry 12, 2, 206-220 (2007).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.